Ohtuvayre (Ensifentrine)-Where to buy Ensifentrine
Ohtuvayre (Ensifentrine) - Ensifentrine is an oral inhaled medication primarily used to control chronic obstructive pulmonary disease (COPD). COPD is a common lung disease, mainly including chronic bronchitis and emphysema, which is characterized by long-term damage to the airways, resulting in difficulty breathing. Exefentine is a phosphodiesterase inhibitor. Its mechanism of action is to relax airways and improve breathing by blocking certain natural substances in the body that cause lung inflammation and muscle contraction.
Ohtuvayre comes in the form of a suspension, which patients convert into an inhalable mist, usually with the help of a nebulizer, and inhale it orally. Under normal circumstances, doctors will recommend that patients inhale once a day in the morning and evening, making sure to do it at about the same time to maintain the effective concentration of the drug. Patients should not increase or decrease the dosage or change the frequency of use at will, and should strictly follow the doctor's prescription. This medication is not the first choice during an acute COPD attack, and patients should use a doctor-prescribed short-acting inhaler for emergencies.
During the use of exefantine, if dyspnea worsens, or if a short-acting inhaler needs to be used more frequently to relieve symptoms, patients should contact their doctor in a timely manner for further evaluation and guidance. The doctor may adjust the treatment plan according to the patient's specific situation to ensure the best treatment effect and safety.
The original research version of Ohtuvayre has not yet been launched in China, so its price and medical insurance policy are still unknown. For domestic patients in need, the drug can currently only be purchased through relevant overseas channels. Up to now, the common specification of Ohtuvayre is 3mg/2.5mL (60 doses). The original American version of Ohtuvayre has been sold in pharmacies in Hong Kong, China. The price of each box may be around HK$44,500, which is equivalent to more than 40,000 RMB. In addition, the price may fluctuate due to the exchange rate. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
Reference materials:https://en.wikipedia.org/wiki/Ensifentrine
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)